Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-05-04 07:00 |
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Busi…
|
English | 110.9 KB | ||
| 2021-04-28 07:00 |
Innate Pharma Publie son Document d'Enregistrement Universel 2020 et son Rappor…
|
French | 129.0 KB | ||
| 2021-04-28 07:00 |
Innate Pharma Files its 2020 Universal Registration Document (Document d'Enregi…
|
English | 110.9 KB | ||
| 2021-04-27 12:27 |
Document d'enregistrement universel 2020
|
French | 6.1 MB | ||
| 2021-04-21 07:00 |
Innate Pharma Annonce la Tenue de son Assemblée Générale 28 Mai 2021
|
French | 123.5 KB | ||
| 2021-04-21 07:00 |
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
|
English | 128.2 KB | ||
| 2021-04-19 07:00 |
NOUVEAU NOMBRE D’ACTIONS ET DE DROITS DE VOTE D’INNATE PHARMA AU 1ER AVRIL 2021
|
French | 114.1 KB | ||
| 2021-04-19 07:00 |
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
|
English | 110.4 KB | ||
| 2021-03-18 07:00 |
Innate Pharma présente ses résultats financiers et l'avancée de son portefeuill…
|
French | 699.5 KB | ||
| 2021-03-18 07:00 |
Innate Pharma reports Full Year 2020 financial results and business update
|
English | 649.2 KB | ||
| 2021-03-16 07:00 |
Innate Pharma announces conference call and webcast for Full Year 2020 financia…
|
English | 130.5 KB | ||
| 2021-03-16 07:00 |
Innate Pharma organise une conférence téléphonique et un webcast pour ses résul…
|
French | 133.6 KB | ||
| 2021-02-24 07:00 |
Number of shares and voting rights of Innate Pharma as of February 1, 2021
|
English | 342.1 KB | ||
| 2021-02-24 07:00 |
Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er février 20…
|
French | 175.5 KB | ||
| 2021-02-17 07:00 |
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare C…
|
English | 315.6 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
